Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 35, Issue 4, 2008, Pages 691-694

  Suzuki, Kei ^a   Ino, Kazuko ^a   Sugawara, Yumiko ^a   Mizutani, Minoru ^a   Sekine, Takao ^a   Katayama, Naoyuki ^a  

^a Matsusaka Chuo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOLOGY; IMMUNOTHERAPY; MALE; PATHOLOGY; PHYSIOLOGY; PRIMARY EFFUSION LYMPHOMA; RADIOGRAPHY; TIME;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOTHERAPY; LYMPHOMA, PRIMARY EFFUSION; MALE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43549122582     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)